RAC 0.93% $1.62 race oncology ltd

Ann: Change in substantial holding, page-119

  1. 2,676 Posts.
    lightbulb Created with Sketch. 10277
    No we had no idea COH was working on Bisantrene - they chose the “low profile” approach on their own.

    The COH paper is very long and very detailed and Bisantrene is only mentioned in passing in the second last paragraph. It is very easy to miss the connection.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.